> Attention spans on mobile are atrocious (notably, the fulcrum is screen size having a neurological impact on ability to pay attention - this is a biological fact) – very little real reading takes place.
If you have any further reading on this please share.
n=1 with exception for scientific papers I do essentially all my reading on my phone and I do not experience any attention difference. I also have my phone on perpetual DnD so notifications and other distractions are not a thing.
I don’t get why’re being downvoted. Without doubt a series of governments were looped in on this decision - naively assuming one or several did not initiate it in the first place - to ensure alignment on current matters and there is no chance BP did not take the opportunity to ensure alignment on future matters.
No, I’ve had stock options too but they’ve turned out worthless.
I don’t know what your seniority is and what you’ve seen but I can assure you it exists, and it’s not unique exceptions. Maybe a good opportunity to interview if you’re feels it’s unattainable where you are now. Plenty of US companies hiring remotely too…
Absolute majority through RSUs, which is why I’m objecting the GP’s claims. The vested stock I’ve reinvested through an ISK in a somewhat broader portfolio over time.
> There are no stories like this one where I live (in Sweden). Absolutely none.
Swedish tax rates on income makes this two to three times as difficult (approaches 60% plus 30% social paid by the employer this includes RSUs as well, plus 25% VAT) but it’s nonsense to claim this doesn’t happen. I am Swedish and have made significantly more in tech than the author. So has many of my friends.
With that said, the only reason I’m still in Sweden is family. The public sentiment about the future is uncomfortably racist and increasingly hostile about fortune making. If you have the mobility my advice is to move. Good luck.
Probably, but for Coinbase to even manage to steer the conversation in this direction it’s a victory. They are the best positioned in the industry to even attempt it and if they’re rejected they are first in line to provide the infrastructure.
They’ve produced an uncanny cgi to illustrate the eVTOL vision[1]. While intrigued by some aspects of it (self driving cars, seemingly clever AI assistants and seamless identification across devices - it’s inevitable) I can’t help thinking it’s a dated perspective of the future of work.
It's quite easy to extrapolate this and in a few steps end up in a boring dystopia.
First it's iPhone photos, then it's all iCloud files, that spills into Macs using iCloud, then it's client side reporting of local Mac files, and somewhere along all other Apple hardware I've filled my home with have received equivalent updates and are phoning home to verify that I don't have files or whatever data they can see or hear that some unknown authority has decided should be reported.
What is the utopian perspective of this which counterbalances the risks for this to be a path worth taking?
To reinforce the notion that you’ve made the right choice and keep you as a long term loyal customer. This is an expressed part of car ad strategies.
For medicinal products I’d be keen to see research on whether a treatment group being re-targeted would report better efficiency of a treatment than a non-retargeted control.
Don’t try to equate Shopify’s app distribution to Apple’s. They’re not the same.
Apple charges commission for your paid application regardless of distribution form because there is only one and you have to use it, the AppStore. Shopify has an optional distribution platform for apps which they charge a fee for. You can distribute your app on your own and avoid the fee.
To me, following modern MS research progress is as exciting of an inward journey as space exploration is an outwards one. In fact to the point where I have considered leaving the tech field within the next 5-10 years to partake in it so it's fun to see this here on HN.
Just 20 years ago the first disease modification treatments were introduced. These were recurring injections of interferon-beta (1b/1a) for a 18-38% reduction in relapses and annual relapse rate (ARR) of 0.256[1]. Today there are about 20 different options, with Rituximab and humanized variants indicating an annual relapse rate of 0.044 for RRMS patients with a well understood safety profile[2]. On such medications an MS patient can expect a relapse every 22 years vs every 2.5 years unmedicated.
My pet theory is that MS research will ultimately lead to significant breakthroughs in longevity research. This is based on the morbid view that the disease is serious enough for risks to be taken in understanding auto-immune responses, crossing the blood brain barrier and remyelination.
Neat project! The example photos in Drive are a bit wonky on mobile and only one of the files is accessible. Consider adding a few example photos in the readme. What’s the licensing and usage rights of the produced images?
I’d rather say Linux gives you choices. Choices that you have to make, rather than options with (sensible) defaults. This is a big reason for why I’ve been unable to switch from macos to Linux as a daily driver every time I’ve tried in the past ten years.
Ironically, it’s simply too costly. Macos has been degrading over the past 6-7 years, but it’s still pretty good at standing out the way.
I’m gladly proven wrong if you can point at a path I’ve missed.
This is off topic, but it's proving hard to google.
What's the significance of the hand gesture the women in the video makes at 1:13 and again at 1:39?
